Health

The FDA Granted Orphan Drug Designation to Biostar Pharma's Utidelone for the Treatment of Pancreatic Cancer

SAN FRANCISCO, Sept. 25, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the US wholly-owned subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd. ("Biostar," stock code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of ...

2025-09-25 21:37 2108

Flat Medical Establishes Clinical Advisory Board for Pain Interventions, Names Dr. Krishnan Chakravarthy as Chairman

AUSTIN, Texas, Sept. 25, 2025 /PRNewswire/ -- Flat Medical, a leading innovator in medical device solutions, today announced the formation of itsClinical Advisory Board for Chronic Pain Interventions and the appointment of Dr. Krishnan Chakravarthy, MD, PhD, as its inaugural Chairman. This strate...

2025-09-25 21:00 1614

iotaMotion Surpasses 1,000 Clinical Procedures Performed with iotaSOFT® --Defining a New Era in Cochlear Implant Surgery

* Fewer than 5% of eligible patients worldwide receive cochlear implants today * Hearing loss is the largest modifiable risk factor for dementia, linked to approximately 8% of global cases — more than hypertension, obesity, smoking, or depression ST. PAUL, Minn., Sept. 25, 2025 /PRNewswire/ -- ...

2025-09-25 20:33 1378

WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™,to Accelerate Biologics Development with High Titer and Superior Stability

* TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability. * The platform has achieved an average mAb titer exceeding 8.0 g/L with over 99% of clonal cell lines maintaining sta...

2025-09-25 19:42 1733

Waterdrop Inc. Published 2024 ESG Report: Expanding Support to Vulnerable Groups, Providing Rural Medical Clinic Access to Over 500 Thousand Beneficiaries

BEIJING, Sept. 25, 2025 /PRNewswire/ -- On September 25th, Waterdrop Inc. released its2024 Environmental, Social and Governance (ESG) Report (hereinafter "the Report"), which offers an in-depth overview of the Company's progress and initiatives in corporate governance, technology innovation, prod...

2025-09-25 13:09 3194

C2F Empowers Chula to Advance Academic Excellence and Research on the Path to Becoming a World-Class University

BANGKOK, Sept. 25, 2025 /PRNewswire/ -- The C2F, or Second Century Fund , of Chulalongkorn University supports research that addresses social, environmental, economic, and national policy challenges. In 2025, over 1,000 scholarships will be awarded, with nearly700 millio...

2025-09-25 10:00 1641

NAVER D2SF Invests in GravityLabs, a Healthcare Startup Helping Users Build Healthy Habits

- Operates "MoneyWalk", a global healthcare platform achieving more than 30 minutes of daily user engagement - Records 40% of users from overseas markets, aiming to leverage rich health data for the CRO sector - NAVER D2SF has been an early investor in healthcare startups since 2017, with expec...

2025-09-25 08:00 1566

Sky Labs Launches CART BP, a Ring-Type Cuffless Blood Pressure Monitor

App-based "Blood Pressure Calendar" enables 24-hour tracking, including nighttime measurements SEOUL, South Korea, Sept. 25, 2025 /PRNewswire/ -- Sky Labs announced the official launch of CART BP, a ring-type personal blood pressure monitor designed for everyday use.

2025-09-25 06:00 1803

ADVANCION PUBLISHES 2024 CORPORATE SUSTAINABILITY REPORT

Fourth annual report highlights continued progress in sustainable innovation, safety, and responsible resource stewardship BUFFALO GROVE, Ill., Sept. 25, 2025 /PRNewswire/ -- Advancion Corporation ("Advancion" or "Company"), a global leader in life science buffers and proprietary specialty ingre...

2025-09-25 02:40 1470

Suvoda and Greenphire complete brand integration with unified website and social media presence

CONSHOHOCKEN, Pa., Sept. 25, 2025 /PRNewswire/ -- Suvoda LLC , a global clinical trial technology company, today announced the completion of its brand integration with Greenphire,...

2025-09-25 00:01 1651

MindHYVE.ai™ Unveils ChironAI™: The World's First AGI-Powered Clinical Decision Support System, Redefining Healthcare Intelligence

NEWPORT BEACH, Calif., Sept. 24, 2025 /PRNewswire/ -- HYVE Labs™ and MindHYVE.ai™ proudly announce the global launch of ChironAI™, an autonomous, next-generation Clinical Decision Support (CDS) system powered by the revolutionary Ava-Healthcare™ AGI reasoning model. Designed from the ground up t...

2025-09-24 22:40 1625

Shaklee® Expands in New Zealand by Acquiring Modere® Assets and Product Rights Including Liquid Biocell® Collagen, Trim, and Natural Mineral Drink

MIAMI, Sept. 25, 2025 /PRNewswire/ -- Shaklee, a global leader and pioneer in the nutrition and wellness industry, is proud to announce the continued expansion of its international presence through the acquisition of select Modere assets inNew Zealand, via a wholly owned subsidiary. This strategi...

2025-09-24 21:19 2110

Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials

SEOUL, South Korea and MONTREAL, Sept. 24, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, today announced a strategic partnership with CellCarta, a globally recognized provider of CRO laboratory services for p...

2025-09-24 21:00 2082

The Hidden Genetic Threat Putting 1 in 5 at Cardiovascular Disease Risk: Global Experts Call for Action on Elevated Lipoprotein(a)

* Cardiovascular disease (CVD) kills nearly 18 million people each year, more than all cancers combined1,2 * Elevated lipoprotein(a) or Lp(a), an inherited condition that raises CVD risk, affects 1 in 5 people worldwide but is rarely tested3 * New survey across Asia Pacific and Middle East s...

2025-09-24 20:21 1600

Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)

SHANGHAI, Sept. 24, 2025 /PRNewswire/ -- Hengrui Pharma (600276.SH; 01276.HK), a leading innovative global pharmaceutical company focused on scientific and technological innovation, announced today that it has entered into an exclusive license agreement with Glenmark Specialty S.A. (GSSA), a whol...

2025-09-24 19:45 1779

GCCL and Frontage Laboratories Announce Strategic Collaboration to Strengthen Global Clinical Trial Capabilities

YONGIN, South Korea, Sept. 24, 2025 /PRNewswire/ -- GCCL (Global Clinical Central Lab), aSouth Korea-based leading provider of clinical trial sample analysis, and Frontage Laboratories, Inc., aUSA based full-service contract research organization (CRO), announced on September 23 that they had sig...

2025-09-24 13:29 1616

Demand for charitable services is increasing around the world, according to new Charities Aid Foundation research

LONDON, Sept. 24, 2025 /PRNewswire/ -- Charities around the world say that demand for their organisation's services has increased over the last year, according to new global research by theCharities Aid Foundation  (CAF).   CAF's World Giving Report: Charity Insights...

2025-09-24 13:00 1426

Singapore International Agri-Food Week 2025 Returns with Focus on Sustainable and Resilient Food Systems in the Asia Pacific

SINGAPORE, Sept. 24, 2025 /PRNewswire/ -- The Singapore International Agri-Food Week (SIAW) 2025 returns from 3-6 November 2025 at the Sands Expo & Convention Centre, uniting global leaders and innovators under the theme 'Accelerating Climate Resilience inAsia-Pacific's Agri-Food System'. SIAW is...

2025-09-24 10:57 3622

Xinhua Silk Road: Guotai Haitong Securities hosts conference on biopharma and AI in E. China's Shanghai

BEIJING, Sept. 24, 2025 /PRNewswire/ -- The 2025 Shanghai pioneering industries conference, hosted by Guotai Haitong Securities, was recently held in east China's Shanghai. The event also featured the 14th pharmaceutical CEO forum and the 5th artificial intelligence (AI) conference. The event bro...

2025-09-24 09:02 2478

LifeSpan Portfolio Company Remedium Signs Landmark Deal with Eli Lilly

NORWALK, Conn., Sept. 24, 2025 /PRNewswire/ -- Lifespan Vision Ventures is pleased to announce that its portfolio company, Remedium Bio, Inc. ("Remedium"), has entered into a multi-target research and development collaboration with Eli Lilly and Company ("Lilly") focused on advancing innovative ...

2025-09-24 00:15 1326
1 ... 48495051525354 ... 872